Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MLTX
- Price
- 38.17
- Stock movement down
- -0.41 (-1.06%)
- Company name
- MoonLake Immunotherapeutics
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.41B
- Ent value
- 2.05B
- Price/Sales
- 60977.53
- Price/Book
- 4.86
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -4.48%
- 3 year return
- 93.24%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-05-29
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MLTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 60977.53 |
| Price to Book | 4.86 |
| EV to Sales | 52036.79 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 63.06M |
| EPS (TTM) | -1.29 |
| FCF per share (TTM) | -1.29 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 39.48K |
| Gross profit (TTM) | -34.48K |
| Operating income (TTM) | -108.54M |
| Net income (TTM) | -81.31M |
| EPS (TTM) | -1.29 |
| EPS (1y forward) | -2.54 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -87.33% |
| Operating margin (TTM) | -214748.36% |
| Profit margin (TTM) | -205968.07% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 375.66M |
| Net receivables | 2.41M |
| Total current assets | 512.32M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 3.83M |
| Total assets | 518.21M |
| Accounts payable | 104.32K |
| Short/Current long term debt | 3.69M |
| Total current liabilities | 20.08M |
| Total liabilities | 22.71M |
| Shareholder's equity | 495.50M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -80.46M |
| Capital expenditures (TTM) | 628.59K |
| Free cash flow (TTM) | -81.09M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -16.41% |
| Return on Assets | -15.69% |
| Return on Invested Capital | -16.35% |
| Cash Return on Invested Capital | -16.31% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 38.83 |
| Daily high | 38.87 |
| Daily low | 37.78 |
| Daily Volume | 222K |
| All-time high | 63.86 |
| 1y analyst estimate | 73.92 |
| Beta | 1.28 |
| EPS (TTM) | -1.29 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MLTX | S&P500 | |
| Current price drop from All-time high | -40.23% | -4.11% |
| Highest price drop | -64.60% | -56.47% |
| Date of highest drop | 16 May 2022 | 9 Mar 2009 |
| Avg drop from high | -22.81% | -11.06% |
| Avg time to new high | 22 days | 12 days |
| Max time to new high | 324 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
2.41B
Marketcap category
Mid-cap
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Employees
50
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
MoonLake, a clinical-stage biopharmaceutical company, is gaining attention with its promising nanobody-based therapies for inflammatory diseases. Read more here.
December 8, 2023
iO Charts is a Seeking Alpha partnerNext page